Form 4: Core Scientific Director Rozov Yadin Acquires Shares and Warrants

Director Rozov Yadin reports purchasing 80,000 shares of common stock and 90,000 Tranche 2 Warrants in Core Scientific, Inc./tx.

Summary

• On March 15, 2024, Rozov Yadin, a director of Core Scientific, Inc./tx, purchased 80,000 shares of common stock at a weighted average price of $3.0746.
• The director also acquired 90,000 Tranche 2 Warrants at a weighted average price of $2.1532.
• The Tranche 2 Warrants have an exercise price of $0.01 per share and can be exercised when the volume weighted average price of Core Scientific's common stock equals or exceeds $8.72 per share for 20 consecutive trading days, subject to adjustments.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. Insider buying can be a positive signal, but it's just one data point to consider.

Positives

• A director's purchase of company stock and warrants can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This filing reflects insider trading activity, which is a common occurrence in publicly traded companies. Investors often monitor these filings for signals about management's confidence in the company's prospects.

Stakeholder Impact

• The purchase of shares and warrants by a director could positively influence shareholder sentiment.

Key Dates